ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

IKA Ilika Plc

27.90
-0.10 (-0.36%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Ilika Plc LSE:IKA London Ordinary Share GB00B608Z994 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.10 -0.36% 27.90 27.00 28.00 28.50 27.50 28.00 262,368 16:35:06
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 702k -7.3M -0.0459 -5.99 43.72M

Ilika plc Half Yearly Report (5042L)

12/01/2016 7:00am

UK Regulatory


Ilika (LSE:IKA)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Ilika Charts.

TIDMIKA

RNS Number : 5042L

Ilika plc

12 January 2016

Ilika plc

('Ilika,' the 'Company,' or the 'Group')

Half Yearly Report

Ilika (AIM: IKA), the accelerated materials innovation company, announces its unaudited half yearly report for the six months ended 31 October 2015. The period has seen continued progress with its solid-state battery development programme, a strengthening of its IP portfolio and constructive discussions with its commercial partners.

Ilika accelerates the discovery of new and patentable materials using its patented high throughput technologies process for identified end uses in the energy, electronics, and aerospace sectors. Its flagship programme is the development of unique solid-state batteries.

Operational Highlights

   --     Data from working prototype batteries shared with potential OEM partners 

-- Alignment and agreement of battery capability with OEM partners, enabling definition of a roadmap of specific battery architectures

   --     Patent granted in China for Ilika's proprietary process to produce solid-state batteries 

-- UK Grant Award of GBP470k to take a lead role in GBP2.15m collaborative programme to develop self-healing alloys for aerospace applications

-- European Patent Office upheld Ilika's opposition to a fuel cell catalyst patent from Brookhaven Science Associates (BSA)

   --     Mike Inglis, former board member and executive of ARM, appointed as Non-Executive Chairman 

Financial Summary

   --     Total revenue for the period of GBP0.3m (1H 2014: GBP0.6m) 
   --     Loss per share of 3p (1H 2014: 2p per share) 
   --     Net cash outflow in the period of GBP1.5m (1H 2014: inflow GBP0.1m) 
   --     Net Cash at period end of GBP4.5m (1H 2014: GBP7.2m) 

As previously announced, during the first half of the year, the Group committed an increasing proportion of its operational resource to the internally funded battery development programme, intended to drive the growth of the business over the coming years. As a consequence, the Group has generated lower revenue and profit from customers than in the prior year.

Commenting on the results Graeme Purdy, CEO of Ilika, said: "Our team has made good progress and breakthroughs with this complex technology and has produced working batteries for evaluation by our target OEM partners. This effort has resulted in interactions which have led to the definition of a detailed product roadmap. We now look forward to advancing these designs and stepping up our commercial interactions with our OEM partners."

 
 Ilika plc 
  Graeme Purdy, Chief Executive 
  Steve Boydell, Finance Director                            +44 (0)23 8011 1400 
 
 NUMIS Securities Limited 
  Oliver Cardigan/ Paul Gillam/ 
  James Black                                               +44 (0) 20 7260 1000 
 
 Walbrook PR Ltd                     +44 (0)20 7933 8780 or ilika@walbrookpr.com 
 Paul Cornelius                                         Mob: +44 (0)7827 879 460 
 Lianne Cawthorne                                       Mob: +44 (0)7584 391 303 
 

Joint Chairman's and CEO's Statement

Review of Period

Ilika has continued to pursue its strategy of deploying its high throughput materials development capabilities in the energy, electronics and aerospace sectors. Ilika maintains a portfolio of activities, with its principal focus being its flagship programme for the development of solid-state batteries.

Solid-state battery technology

Ilika has been active in the development of solid-state battery technology since 2008, when it commenced a collaboration with Toyota, principally to develop materials suitable for use in batteries for hybrid vehicles. In the course of that collaboration Ilika and Toyota have filed joint patent applications protecting relevant materials and processes. The key advantages of solid-state batteries relative to standard lithium-ion batteries are:

   --     Non flammable 
   --     6 x faster charging 
   --     4x longer charge retention 
   --     2x increased energy density, making them half the volume for a given charge 

Ilika has identified that these benefits also make the batteries suitable for applications outside of the automotive sector. In particular, Ilika has defined a commercially-oriented, detailed product roadmap for its initial target market, which is micro-batteries for the "Internet of Things" (IoT).

Ilika's battery technology is differentiated from other solid-state batteries through its choice of materials and its use of an efficient evaporation process that is capable of higher deposition rates than other solid-state routes. This results in the following benefits relative to previous solid-state battery designs:

-- Ability to stack cells in a continuous process prior to encapsulation, increasing the energy capacity per footprint of battery

   --     Less encapsulation required 
   --     High temperature resilience 

Within the IoT market, there are a number of segments which are addressable with Ilika's technology. The largest market for IoT connected devices is in domestic homes and commercial buildings (smart buildings). Typical devices in smart buildings measure light, temperature and humidity, feeding into lighting and Heating Ventilation and Air Conditioning systems. Currently, most of the systems deployed in smart buildings are hard-wired, resulting in significant installation costs. Deploying battery-powered sensors reduces installation costs, particularly for the retrofit of existing buildings, but such batteries must be rechargeable to avoid high maintenance costs associated with regular battery replacement. In this context, Ilika's battery technology offers the benefit of being suitable for combination with energy harvesting devices. The most readily available energy harvesters are photovoltaic panels, which are becoming increasingly efficient and cost effective.

The specific benefits of Ilika's battery technology for this application are a small battery footprint, a long battery life (expected to be 10 years), the ability to discharge rapidly when a burst of data transmission is required and finally, the ability to be trickle charged by the small electrical currents typically generated my such small harvesting devices.

Another segment of interest is transport applications, including automotive and aerospace, where using distributed batteries and energy harvesters can reduce the significant capital and operating cost of the cabling currently required to connect instrumentation. The high temperature resilience of Ilika's batteries is one of the key benefits relevant here.

A further addressable market is the healthcare sector. Ilika's batteries can enable miniature medical devices in a way that is currently not possible with conventional lithium-ion batteries. Also, the use of wireless technology and distributed sensors can create patient monitoring solutions with substantial cost reduction and enhanced care benefits.

The product that Ilika will market to its partners will be a licensing package including the following:

   --     Battery architecture design 
   --     Detailed definition of the materials composition and properties 
   --     Manufacturing process description 
   --     Sample battery devices and supporting system 
   --     IP portfolio 

Following the commencement of pilot production of solid-state batteries in March 2015, Ilika has been optimising the performance of the equipment and the batteries and has shared performance data for evaluation by commercial partners.

The first product on Ilika's roadmap is code-named "Pelican", which is expected to be launched in H1 2016 and is designed to address multiple opportunities identified in the above discussion on addressable markets. It will provide a basis for further product lines going forward.

Commercial Progress

Ilika's intention is to license its technology to OEM partners using the model that has become familiar in the semiconductor industry, based on license fees and royalties. Through the use of its pilot line, Ilika is also able to provide initial quantities of product to seed the market for OEM's. Licensing may also involve the use of 3(rd) party foundries working under contract to OEM's.

Ilika has continued to pursue a three-phase strategy to the commercialisation of its battery technology:

   --     Optimisation of the battery architecture for specific applications 
   --     Validation and integration of the batteries into application systems 
   --     Technology transfer and licensing for manufacture 

The development of the roadmap is demonstration of the implementation of the first phase of this strategy. This phase will continue to run in parallel with second phase, which has now commenced. The first two phases are creating a pipeline of commercialisation opportunities underpinning the future revenue growth of the company.

Intellectual Property Reinforcement

Ilika has continued to support the filing and prosecution of patents protecting its proprietary intellectual property (IP) in solid-state batteries. In September 2015, Ilika received a Notice of Grant in China for its patent application supporting solid-state batteries jointly filed with Toyota Motor Company on 21 July 2011. This notice followed the successful British grant in May 2014 and the European grant in July 2015. This filing resulted from collaborative work undertaken by Ilika and Toyota, which commenced in 2008. This patent family is one of the two earliest filings of a growing portfolio of IP exemplifying Ilika's unique approach to solid-state battery production using evaporation sources. More recent applications in the portfolio contain both jointly-owned and solely-owned IP.

Materials Development Portfolio

(MORE TO FOLLOW) Dow Jones Newswires

January 12, 2016 02:00 ET (07:00 GMT)

In addition to its flagship product development programme for solid-state batteries, Ilika has continued to support an active portfolio of materials development projects. Over the first half of the current financial year, around 75% of Ilika's resources were deployed in solid-state battery development, 15% in alloys for aerospace and 10% in materials for electronics.

The largest aerospace alloy project was the continuation of the GBP1.3 million grant-funded superalloy development project which started in April 2014 with the University of Cambridge, Diamond Light Source and Rolls Royce. In September 2015 Ilika announced that it had been awarded a further GBP466,000 grant for research and technology into self-healing alloys, as part of a lead role in a GBP2.15 million, three-year collaborative project with Reliance Precision Engineering, University of Sheffield, GKN and BAE Systems. This latest project has two objectives: the development of a new generation of self-healing alloys suitable for additive manufacturing (AM) and secondly the development of manufacturing processes combining the flexibility of AM with the precision of subtractive (conventional) machining.

Board

In July 2015, Ilika announced the appointment of Mike Inglis as a Non-Executive Director, who subsequently took over from Jack Boyer OBE as Non-Executive Chairman following Mike's successful election at the AGM in September 2015. Mike is also a Non-Executive Director of BT and an Independent Director of US-based Advanced Micro Devices Inc (AMD). He was formerly Chief Commercial Officer at ARM Holdings plc until March 2013, having previously been EVP of ARM's Processor Division and EVP Sales and Marketing. Mike's appointment is particularly pertinent to Ilika's ambition to commercialise its know-how through licensing models successfully deployed by ARM in the semiconductor sector.

Outlook

Sustained technical progress in 2015 has resulted in Ilika being in a strong position to intensify its interactions with OEM partners going forward. In 2016, the Company expects to make further progress with the implementation of its roadmap, including entering into a series of technology integration projects designed to bring IoT solutions to the market.

Graeme Purdy, CEO

Mike Inglis, Chairman

Ilika plc

Consolidated statement of comprehensive income for the six months ended 31 October 2015

 
                                                  Unaudited       Unaudited        Audited 
                                                  Six months      Six months         Year 
                                                    ended           ended           ended 
                                                 31 Oct 2015     31 Oct 2014     30 Apr 2015 
                                        Notes        GBP             GBP             GBP 
-------------------------------------  ------  --------------  --------------  -------------- 
 
 Revenue                                              253,693         606,328       1,093,978 
 Cost of sales                                      (166,881)       (339,458)       (591,044) 
                                               --------------  --------------  -------------- 
 
 Gross profit                                          86,812         266,870         502,934 
 
 Administrative expenses                          (1,980,137)     (1,866,561)     (3,588,837) 
                                               --------------  --------------  -------------- 
 
 Operating loss                                   (1,893,325)     (1,599,691)     (3,085,903) 
 
 Financial income                                      18,162          27,080          50,557 
 
 
 Loss before tax                                  (1,875,163)     (1,572,611)     (3,035,346) 
 Taxation                                             203,423         167,500         333,647 
 
 Loss for period/total comprehensive 
  income attributable to owners 
  of parent                                       (1,671,740)     (1,405,111)     (2,701,699) 
 
 Loss per share                           2 
 Basic and diluted                                     (0.03)          (0.02)          (0.04) 
                                               --------------  --------------  -------------- 
 

The results from the periods shown above are derived entirely from continuing operations.

Consolidated balance sheet as at 31 October 2015

 
                                                 Unaudited       Unaudited       Audited 
                                                 Six months      Six months        Year 
                                                    ended          ended           ended 
                                                 31 Oct 2015    31 Oct 2014       30 Apr 
                                                                                   2015 
                                       Notes        GBP             GBP            GBP 
------------------------------------  -------  -------------  --------------  ------------- 
 ASSETS 
 Non current assets 
 Intangible assets                                    22,102          35,192         30,119 
 Property, plant and equipment                       486,540         553,246        560,698 
                                               -------------  --------------  ------------- 
 
 Total non current assets                            508,642         588,438        590,817 
                                               -------------  --------------  ------------- 
 
 Current assets 
 Trade and other receivables                         525,374         636,454        496,985 
 Current tax receivable                              175,000         137,975        304,122 
 Other financial assets - bank 
  deposits                                           536,461       6,052,336        528,349 
 Cash and cash equivalents                         4,005,500       1,202,433      5,479,035 
                                               -------------  --------------  ------------- 
 
 Total current assets                              5,242,335       8,029,198      6,808,491 
                                               -------------  --------------  ------------- 
 
 Total assets                                      5,750,977       8,617,636      7,399,308 
                                               -------------  --------------  ------------- 
 
 
 Issued capital and reserves attributable 
  to owners of parent 
 Issued share capital                                663,779         658,836        663,748 
 Share premium                                    17,467,077      17,391,768     17,465,442 
 Capital restructuring reserve                     6,486,077       6,486,077      6,486,077 
 Retained earnings                              (19,673,197)    (16,831,890)   (18,094,830) 
                                               -------------  --------------  ------------- 
 
 Total equity                                      4,943,736       7,704,791      6,520,437 
                                               -------------  --------------  ------------- 
 
 
 LIABILITIES 
 Current liabilities 
 Trade and other payables                            657,241         762,845        728,871 
 Provisions                                          150,000         150,000        150,000 
                                               -------------  --------------  ------------- 
 
 Total liabilities                                   807,241         912,845        878,871 
                                               -------------  --------------  ------------- 
 
 Total equity and liabilities                      5,750,977       8,617,636      7,399,308 
                                               -------------  --------------  ------------- 
 

Consolidated cash flow statement for the six months ended 31 October 2015

 
                                               Unaudited      Unaudited       Audited 
                                               Six months     Six months        Year 
                                                  ended          ended          ended 
                                               31 Oct 2015    31 Oct 2014    30 Apr 2015 
                                                  GBP            GBP            GBP 
-------------------------------------------  -------------  -------------  ------------- 
 Cash flows from operating activities 
 Loss before taxation                          (1,875,163)    (1,572,611)    (3,035,346) 
 Adjustments for: 
 Amortisation                                        8,017          4,644         12,736 
 Depreciation                                      143,154        190,999        324,556 
 Equity settled share based payments                93,373              -         33,648 
 Net financial income                             (18,162)       (27,080)       (50,557) 
                                             -------------  -------------  ------------- 
 Operating cash flow before changes 
  in working capital, interest and 
  taxes                                        (1,648,781)    (1,404,048)    (2,714,963) 
 Decrease/(increase) in trade and 
  other 
  receivables                                     (28,389)       (64,150)         79,918 
 Increase /(decrease) in trade and 
  other payables                                  (71,630)        152,098        118,124 
                                             -------------  -------------  ------------- 
 Cash utilised by operations                   (1,748,800)    (1,316,100)    (2,516,921) 
 Tax received                                      332,545        277,716        277,716 
                                             -------------  -------------  ------------- 
 Net cash flow from operating activities       (1,416,255)    (1,038,384)    (2,239,205) 
 
 Cash flows from investing activities 
 Interest received                                  18,162         27,080         45,958 

(MORE TO FOLLOW) Dow Jones Newswires

January 12, 2016 02:00 ET (07:00 GMT)

1 Year Ilika Chart

1 Year Ilika Chart

1 Month Ilika Chart

1 Month Ilika Chart

Your Recent History

Delayed Upgrade Clock